21 - 22 June 2016, Lausanne, Switzerland.The 2016 Healthtech Summit is the leading independent European event for investment in Digital Health and Medtech. The summit attracts influential and reliable Venture Capital and Private Equity leaders, Life Sciences Industry experts and Entrepreneurs offering the chance to accelerate investments and generate quality networking opportunities.
The event features presentations from the 20 best European Digital Health Companies and the 20 best Medical Device companies. Forty companies, both early and growth stage, carefully selected by two dedicated expert selection committees, include some of the most experienced and active digital health investors such as DRX capital (Qualcomm/Novartis), Hightech Gruenderfonds, Merck Global Health Innovation Fund, Orbimed, Peppermint Ventures, XL Health, as well as industry leaders such as Allianz, Boston Scientific, Medtronic, Nokia and Samsung.
The 2016 Healthtech Summit will feature 3 learning and panel sessions highlighting the latest and most inspirational innovations and experiences in digital health:
1. Designing Digital Health Solutions, Business Models & Ecosystems, with an introductory presentation on "design due diligence" by Frog Design and moderated by Healthware International
2. Digital Therapeutics, with introductory presentations on "redefining patient outcomes" by PatientsLikeMe, and "creating digital health IP" by Hogan Lovells
3. Convergence of Life Sciences & Digital Health, with an introductory presentation on "digital health acquisitions by pharma" by Accenture
Meet the Entrepreneurs and Innovators at the Keynote Stage who will welcome speakers including:
- Arda Ural, Managing Director at Accenture Strategy Life Sciences
- Julie Meyer, Founder and Chief Executive of Ariadne Capital
- Thomas Sutton, Executive Creative Director at Frog Design
- Gabriel Scali, Design Partner at Healthware International
- Stephen Bennett, Partner at Hogan Lovells
- Matic Meglic, Digital Health Director at Medtronic
- Ahmed Albaiti, Founder and CEO of Medullan
- Francisca Wuttke, Managing Director at Merck Global Health Innovation Fund
- Steven Yecies, Venture Partner at OrbiMed Advisors
- Chris Fidyk, Vice President of Strategic Business Development at PatientsLikeMe
- Klaus Stöckemann, Managing Director at Peppermint Venture Partners
- Monishia zu Eltz, Vice President of Strategic Alliances and Partnering at Philips
The presenting digital health companies, selected out of a record number of applicants, represent 9 European countries and solutions in several key areas, such as: patient engagement, virtual care, health IT, devices & sensors, digital diagnostics, digital therapeutics, data & analytics and clinical trial management. 40% of the companies already have 20 employees or more, and many are currently planning to raise investments, with round sizes ranging from $0.5M to $16M.
Roberto Ascione, CEO of Healthware International is leading the 2016 edition: "The number and quality of companies reviewed shows how the European digital health landscape is growing rapidly and the Summit will be a perfect opportunity to discover companies, discuss access to capital, analyse best practices and to keep building a solid ecosystem for health transformation in Europe"
The Healthtech Summit will take place at IMD, one of the world's leading business schools, in Lausanne; the evening of June 21 a networking dinner will take place at the Olympic Museum.
For further information, please visit:
http://www.techtour.com/healthtechsummit2016
About Tech Tour
Tech Tour was founded by VC Sven Lingjaerde (Endeavour Vision) in 1998, and acts as a platform to foster interactions through a range of pan-European regional & industry sector events. The scope of the events, the content and selection processes are driven by volunteer investors & IVC members.
The Healthtech Summit is the leading independent European platform for investment in Digital Health and Medtech since the 1st edition in 2008. Digital Health is part of the scope of the Healthtech Summit since 2014, and is quickly becoming the dominant component. The event is focused and interactive, with networking sessions, panel discussions, company presentations and ample opportunity to network, share insights and learn more about emerging trends. This offers entrepreneurs direct access to a unique ecosystem of investors, corporate partners as well as peers, to facilitate fundraising and partnerships. Investors and Corporate participants gain direct access to the most promising Digital Health and Medtech investment, acquisition & partnership opportunities.
About Canton de Vaud
The mission of the Department for Economic Affairs of the State of Vaud is to put in place the framework conditions required to promote economic growth. Its objectives are designed to highlight the know-how of companies and to make the canton an attractive and competitive environment.
The vitality of economy in the Canton of Vaud is particularly remarkable in state-of-the-art industries with high added value such as life sciences, information technology, micro- and nanotechnology, environmental and agri-food technologies. Strong political support and many concrete state support and incentives serve to reinforce growth in these sectors.